SCHEMBL948297

SCHEMBL948297

CCSc1ccccc1Nc1ccccc1SCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 2/20 0.47
▸ ADRA2B P18089 2/20 0.47
▸ ADRA2C P18825 2/20 0.47
▸ ADRA1D P25100 2/20 0.47
▸ ADRA1A P35348 2/20 0.47
▸ ADRA1B P35368 2/20 0.47
▸ HPGD P15428 5/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ CETP P11597 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HDAC3 O15379 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14383870 0.84 ADRA2A (0.46) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL27993116 0.83 ADRA2A (0.45) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL17325503 0.83 ADRA1D (0.53) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL23302280 0.83 ADRA2A (0.45) ADRA2AADRA2BADRA2CADRA1DADRA1A
Hydrochloric Acid SCHEMBL23302378 0.81 ADRA2A (0.47) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL9793625 0.80 S100A4 (0.41) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL19601473 0.79 ADRA2A (0.43) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL24125024 0.78 ADRA2A (0.42) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL22169133 0.78 ALDH1A1 (0.44) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL31231922 0.75 ALDH1A1 (0.50) ADRA1DADRA1AADRA1BHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456152-B1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECH PTY LTD (ZA) 2012-06-13 — — EP claimed
JP-4308015-B2 — — 2009-08-05 — — JP claimed
US-7300904-B2 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2007-11-27 — — US claimed
JP-2005533872-A — — 2005-11-10 — — JP claimed
US-20050131262-A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2005-06-16 — — US claimed
EP-1456152-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST Sasol Technology (Pty) Ltd (ZA) 2004-09-15 — — EP claimed
WO-2003053890-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECHNOLOGY (PTY) LTD (ZA) 2003-07-03 — — WO claimed
EP-2287144-B1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-04-11 — — EP disclosed
EP-2287143-B1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2018-04-11 — — EP disclosed
US-20170044275-A9 Methods of Preparation of an Olefin Oligomerization Catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP 2017-02-16 — — US disclosed
US-9550841-B2 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2017-01-24 — — US disclosed
US-20160251455-A1 Methods of Preparation of an Olefin Oligomerization Catalyst CHEVRON PHILLIPS CHEMICAL CO LP (US) 2016-09-01 — — US disclosed
EP-1716089-B1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL CO (US) 2015-04-08 — — EP disclosed
EP-1716089-A1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST Chevron Phillips Chemical Company LP (US) 2006-11-02 — — EP disclosed
WO-2005082816-A1 METHODS OF PREPARATION OF AN OLEFIN OLIGOMERIZATION CATALYST CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2005-09-09 — — WO disclosed
US-20050187391-A1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY LP 2005-08-25 — — US disclosed
US-20050187098-A1 Methods of preparation of an olefin oligomerization catalyst CHEVRON PHILLIPS CHEMICAL COMPANY, LP 2005-08-25 — — US disclosed
US-20050131262-A1 Trimerisation and oligomerisation of olefins using a chromium based catalyst SASOL TECHNOLOGY (PTY) LTD. (ZA) 2005-06-16 — — US disclosed
EP-1456152-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST Sasol Technology (Pty) Ltd (ZA) 2004-09-15 — — EP disclosed
WO-2003053890-A1 TRIMERISATION AND OLIGOMERISATION OF OLEFINS USING A CHROMIUM BASED CATALYST SASOL TECHNOLOGY (PTY) LTD (ZA) 2003-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187391-A1 Methods of preparation of an olefin oligomerization catalyst ZRANB2, COG4, PPOX ADRA2A 4041/4885ADRA2B 3946/4885ADRA2C 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback